Lexicon Pharmaceuticals, Inc. (LXRX) — Analysis Summary

Lexicon Pharmaceuticals, Inc. (LXRX) has a market cap of $968.35M with year-over-year revenue growth of +729.9%. Net margin stands at -101.1%. The stock trades at a P/E ratio of -37.1.

Key Takeaways

• Revenue changed +729.9% year-over-year
• Net margin of -101.1%
• P/E ratio of -37.1

Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, LXRX posted revenue growth of +729.9% and trades at a P/E of -37.1.